A1920 The Effects of Lead Exposure on the Activities of d-Aminolevulinic Acid Dehydratase (ALAD) with the Modification of the Relative Genotypes

Monday, March 19, 2012
Ground Floor (Cancun Center)
Hung-yi Chuang, Occupational and Environmental Medicine, Kaohsiung Medical University Hospital, Kaohsiung City, Taiwan
Yu-wen Chiu, Department of Family Medicine, Ta-Tung Municipal Hospital, Kaohsiung City, Taiwan
Te-yu Liu, Graduate Institute of Occupational Safety and Health, Kaohsiung Medical University, Kaohsiung City, Taiwan
Introduction
To investigate the effects of blood lead and other related factors on δ-aminolevulinic acid dehydratase (ALAD) activity in lead workers.

Methods
In 121 lead workers and 117 reference subjects, the following data were collected from health examination: blood lead, BMI, glucose AC, and Hct. A questionnaire including of demographic data, medical history, smoking and alcohol consumption was completed by each of subjects. ALAD activity was determined by the standardized method of the European Community. ALAD genotyping was using a method of PCR-RFLP.

Results
In this study, 229 ALAD1-1 homozygotes (96.2%), 8 ALAD1-2 heterozygotes (3.8%) were identified, and none of ALAD2-2 homozygote was observed. Blood lead levels in lead workers and reference subjects were 19.5 µg/dL (SD = 14.7) and 2.9 µg/dL (SD = 1.9), respectively. Lead workers had significantly lower ALAD activity then reference subjects (42.6 ± 22.4 U/L vs. 64.3 ± 13.8 U/L, P < 0.001). According to the multiple regression results, the following independent variables were significant related to ALAD activity: ALAD activity in females were much lower 8.15 U/L then males (P < 0.001); blood lead and glucose AC were inversely associated with ALAD activity (P < 0.001), but the effect of blood lead was profound. The regression coefficients of blood lead and glucose AC were 1.04 and 0.11, respectively. Individuals with alcohol consumption showed lower ALAD activity (P = 0.049). The possible threshold value of blood lead for ALAD activity was determined around 10 µg/dL.

Discussion
In conclusions, ALAD activity was inhibited by lead sensitively and stoichiometrically, thus ALAD activity may be adopted as a reliable biomarker of lead toxicity in humen.